However, several peculiar features of the tumor microenvironment—such as lack/low T cell infiltration, low type 1 T-helper cell response, reduced immune cytotoxic mechanisms or increased TGF-β levels—predict adverse outcomes in colorectal cancer patients. Here, TGFB1 is linked to neoplasm.